Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a non-coding RNA transcript that is antisense to the coding regions of the guanylate binding protein 7 (GBP7) and guanylate binding protein 2 (GBP2) genes. It is annotated as LOC105378842 and is cataloged under Ensembl accession ENSG00000286802. There is no evidence that this transcript encodes a protein, acts as a receptor, enzyme, transporter, or other conventional druggable target. There are no functional studies or disease associations reported for this locus, and it is not a recognized therapeutic target. Some genomic databases may include this as a reference transcript without experimental validation.\n\nKey points:\n- This is not an established therapeutic target—it is a non-coding transcript, likely a product of the genomic overlap between GBP7 and GBP2 loci.\n- There is no established protein product, no interaction with drugs, and no described disease association.\n- There is no evidence supporting a functional classification such as receptor, enzyme, transcription factor, etc.\n- The entry is likely included on genomic annotations for completeness, not due to known biological activity.\n\nIf you are seeking information relevant to guanylate binding protein 2 (GBP2) or guanylate binding protein 7 (GBP7), those are protein-coding genes involved in immune response[3][7], but ENSG00000286802 refers to neither of those proteins, but rather to an antisense non-coding transcript overlapping their loci.\n\nIf you intended to query a canonical protein target, please confirm or consider if you meant "GBP2" or "GBP7" instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to GBP7 and GBP2 (ENSG00000286802).